FIELD: medicine, pharmaceutics.
SUBSTANCE: dosage form contains a physiologically active substance (A), with the exception of tramadol hydrochloride and oxycodone hydrochloride, optionally one or more physiologically compatible pharmaceutical aids (B), synthetic or natural polymer (C) and optionally natural, semisynthetic or synthetic wax (D). Polymer (C) is chosen from the group including polyalkylene oxide, polyethylene, polypropylene, polyvinylchloride, polycarbonate, polystyrene, polyacrylate, their copolymers and mixtures. The dosage form according to the invention, exhibits breaking strength at least 400 H and under the physiologic conditions after 5 h, release maximum 99% of the physiologically active substance (A).
EFFECT: dosage form is mechanically stabilised; it reduces overdose risk invoked by the abuse and inadequate application, particularly chewing, grinding and pestling.
30 cl, 7 dwg, 17ex
Title | Year | Author | Number |
---|---|---|---|
DEGRADATION-RESISTANT DOSAGE FORM WITH DELAYED RELEASE OF OXYCODONE HYDROCHLORIDE | 2010 |
|
RU2461381C2 |
MEDICINAL FORM PROTECTED AGAINST NON-INTENDED USE | 2004 |
|
RU2354357C2 |
DESTRUCTION-RESISTANT DOSAGE FORM CONTAINING ANIONIC POLYMER | 2011 |
|
RU2607499C2 |
DRUG DOSAGE FORM, PROTECTED FROM UNINTENDED APPLICATION | 2004 |
|
RU2339365C2 |
DESTRUCTION-RESISTANT DOSAGE FORM CONTAINING AN INORGANIC SALT | 2011 |
|
RU2604676C2 |
TABLETS PREPARATION TECHNOLOGY FOR CGRP-ACTIVE COMPOUNDS | 2015 |
|
RU2696578C1 |
HOT-MELT EXTRUDED PHARMACEUTICAL DOSAGE FORM | 2010 |
|
RU2547555C2 |
DOSAGE FORM PROTECTED FROM UNINTENDED USE AND CONTAINING (1R, 2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)PHENOL | 2005 |
|
RU2393847C2 |
DRUG FORM | 2009 |
|
RU2493830C2 |
PROTECTED AGAINST UNADMINISTERED APPLICATION PERORAL MEDICATION FORM | 2005 |
|
RU2396944C2 |
Authors
Dates
2010-09-20—Published
2006-02-06—Filed